Creative Diagnostics Launches Comprehensive Suite of HSV Animal Model Services to Support Antiviral Research

Share this news:

Creative Diagnostics launches Herpes Simplex Virus (HSV) Animal Model services to the research community.

-- As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its Herpes Simplex Virus (HSV) Animal Model services to the research community. These HSV animal models can provide scientists with critical in vivo tools to investigate the complex biology, pathogenesis, and immune response associated with HSV-1 and HSV-2, which will help to accelerate the development of new therapeutics and vaccines.

HSV is primarily classified into two types, HSV-1 and HSV-2. HSV-1 and HSV-2 are among the most common human viruses globally. HSV-1 typically infects the mucosal epithelium of the oral cavity or eyes, causing cold sores or herpetic stromal keratitis (HSK), while HSV-2 is the primary cause of genital herpes. HSK is a form of corneal inflammation that can lead to blindness, and it originates from a primary HSV-1 infection followed by viral latency in sensory and autonomic ganglia. Most cases result from reactivation of the latent infection. Animal models are crucial for investigating HSK pathogenesis and therapeutic approaches. Mice and rabbits are the most commonly used animal models for studying HSV-1 latency, reactivation and recurrence.

As a leading service provider in infectious disease research, Creative Diagnostics is dedicated to advancing the understanding of the herpes simplex virus by developing reliable animal models. The company's mission is to provide clients with cutting-edge tools and innovative methodologies to explore the complex biological mechanisms of HSV, including its molecular structure, pathogenic pathways, disease progression and immune defence systems.

An ideal HSV animal model must possess key characteristics such as an immune system identical to that of humans, reproductive tract anatomy consistent with humans, and cellular components that interact with HSV immune evasion mechanisms corresponding to human cells. Creative Diagnostics' research team has successfully developed a series of animal models specifically engineered for HSV research. These include the HSV vaginal infection mouse model, the HSV brain infection mouse model, the HSV-induced rabbit keratitis model and the HSV-induced guinea pig skin injury model. Each model is meticulously designed to balance unique advantages with inherent limitations.

Leveraging an advanced animal model technology platform, Creative Diagnostics offers multiple HSV latent infection inoculation protocols, including intranasal, digital, corneal scratch, tail vein, and tooth extraction inoculations. Models can be customized to meet specific research requirements by adjusting key experimental parameters such as the animal species, age, genotype, the route of infection, the viral serotype, strain and dose.

Creative Diagnostics offers comprehensive services to support enterovirus animal model research. These services include study design and implementation, pathological analysis, immunological response profiling, in vivo pharmacokinetic studies and efficacy-toxicity assessments. Researchers can use these services to investigate acute, latent and recurrent HSV-1 and HSV-2 diseases, explore the precise mechanisms of HSV-mediated pathologies and develop and evaluate therapeutic agents and vaccines against HSV infection.

Creative Diagnostics is committed to empowering scientists to pioneer new approaches to HSV prevention, diagnosis and therapeutic interventions. For more information on these models or related innovative solutions for preclinical research involving infectious diseases, please visit https://antiviral.creative-diagnostics.com/hsv-animal-model.html.

About Creative Diagnostics

Headquartered in New York, Creative Diagnostics is a consulting and experimental service provider specializing in virology and microbiology. The company provides comprehensive solutions to conquer obstacles in virology and microbiology research, from high-security infrastructure provision, biosafety regulation elucidation, to expert viral system assistance.

Contact Info:
Name: Thomas Schmitt
Email: Send Email
Organization: Creative Diagnostics
Website: https://antiviral.creative-diagnostics.com/

Release ID: 89176669

CONTACT ISSUER
Name: Thomas Schmitt
Email: Send Email
Organization: Creative Diagnostics
REVIEWED BY
Editor Profile Picture
This content is reviewed by our News Editor, Diana W..

If you need any help with this piece of content, please contact us through our contact form
SUBSCRIBE FOR MORE